PfizerPFEEarnings & Financial Report
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.
PFE Q3 2025 Key Financial Metrics
营收
$16.7B
毛利润
$12.5B
营业利润
N/A
净利润
$3.5B
毛利率
74.9%
营业利润率
N/A
净利率
21.3%
同比增长
-5.9%
EPS
$0.62
资金流向
Pfizer Q3 2025 Financial Summary
Pfizer reported revenue of $16.7B for Q3 2025, with a net profit of $3.5B (21.3% margin). Cost of goods sold was $4.2B, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $16.7B |
|---|---|
| Net Profit | $3.5B |
| Gross Margin | 74.9% |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Pfizer Annual Revenue by Year
Pfizer annual revenue history includes year-by-year totals (for example, 2024 revenue was $63.6B).
| Year | Annual Revenue |
|---|---|
| 2024 | $63.6B |
| 2023 | $62.5B |
| 2022 | $101.7B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $13.23B | $14.88B | $13.28B | $17.70B | $17.76B | $13.71B | $14.65B | $16.65B |
| 同比增长 | -41.5% | N/A | -27.3% | 39.0% | 34.2% | -7.8% | 10.3% | -5.9% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $215.02B | $221.09B | $216.19B | $219.48B | $213.40B | $208.03B | $206.09B | $208.73B |
| 总负债 | $117.82B | $128.54B | $128.22B | $126.92B | $124.90B | $117.39B | $117.08B | $115.64B |
| 股东权益 | $96.93B | $92.28B | $87.70B | $92.29B | $88.20B | $90.34B | $88.69B | $92.80B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $5.24B | $1.09B | $-1.78B | $6.71B | $6.72B | $2.33B | $-582.0M | $4.60B |
Other Health Care Companies
BMY
Bristol Myers Squibb
营收
$12.5B
净利润
$1.1B
JNJ
Johnson & Johnson
营收
$24.6B
净利润
$5.1B
LLY
Lilly (Eli)
营收
$19.3B
净利润
$6.6B
MRK
Merck & Co.
营收
$17.3B
净利润
$5.8B
VTRS
Viatris
营收
$3.7B
净利润
N/A
ZTS
Zoetis
营收
$2.4B
净利润
$603.0M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M